Kristen Marie Williams is CAO at Pacira Pharmaceuticals, Inc. (PCRX). They have made 21 open-market trades across 1 company since 2016, most recently 2023-06-14.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 21 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PCRX | 25,375 | $922K |
Shares reported on the most recent Form 4, priced at the 2023-06-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PCRX | SELL · 10b5-1 | 2023-06-14 | 2023-06-16 | $37.03 | $479K | -3.4% | -7.7% | -15.0% |
| PCRX | SELL | 2023-06-06 | 2023-06-07 | $38.42 | $204K | +9.4% | +1.4% | -7.0% |
| PCRX | SELL | 2022-06-06 | 2022-06-08 | $60.37 | $1.0M | -9.5% | -2.7% | -12.5% |
| PCRX | SELL | 2022-03-21 | 2022-03-23 | $72.67 | $1.1M | +3.7% | -0.1% | -28.9% |
| PCRX | SELL | 2022-02-16 | 2022-03-01 | $67.01 | $138K | +5.1% | +12.9% | -6.4% |
| PCRX | SELL | 2022-02-10 | 2022-02-14 | $65.18 | $104K | +4.0% | +10.6% | -1.5% |
| PCRX | SELL | 2022-02-04 | 2022-02-08 | $65.18 | $130K | +0.4% | +12.0% | -6.6% |
| PCRX | SELL · 10b5-1 | 2022-01-21 | 2022-01-25 | $65.41 | $13K | +2.7% | +2.1% | +21.9% |
| PCRX | SELL | 2022-01-18 | 2022-01-20 | $65.27 | $3.3M | -2.1% | -1.6% | +18.1% |
| PCRX | SELL | 2021-06-10 | 2021-06-11 | $59.60 | $678K | -0.2% | -6.1% | -7.1% |
| PCRX | SELL | 2021-06-04 | 2021-06-08 | $61.04 | $480K | -1.9% | -7.4% | -7.2% |
| PCRX | SELL | 2021-04-13 | 2021-04-15 | $66.95 | $2.9M | +0.8% | -4.0% | -13.5% |
| PCRX | SELL | 2020-09-15 | 2020-09-17 | $59.77 | $9.8M | -2.5% | -10.2% | -2.4% |
| PCRX | SELL | 2020-06-04 | 2020-06-08 | $47.95 | $797K | -6.4% | +18.8% | +26.3% |
| PCRX | SELL | 2019-08-14 | 2019-08-16 | $39.49 | $494K | -6.7% | -2.7% | +10.1% |
| PCRX | SELL | 2019-06-04 | 2019-06-06 | $42.91 | $217K | +3.1% | +1.9% | -13.9% |
| PCRX | SELL | 2018-08-14 | 2018-08-16 | $47.04 | $449K | -1.8% | +0.2% | +3.0% |
| PCRX | SELL | 2018-06-04 | 2018-06-06 | $33.02 | $135K | -1.3% | -9.8% | +23.9% |
| PCRX | SELL | 2017-11-16 | 2017-11-20 | $40.00 | $486K | +7.2% | +1.5% | -25.9% |
| PCRX | SELL | 2017-08-15 | 2017-08-17 | $36.75 | $254K | +2.2% | +1.3% | +8.0% |
| PCRX | SELL | 2017-06-05 | 2017-06-07 | $43.32 | $163K | +2.9% | +16.1% | -15.0% |
| PCRX | SELL | 2017-05-15 | 2017-05-17 | $50.86 | $2.1M | -5.9% | -12.3% | -23.2% |
| PCRX | SELL | 2016-06-06 | 2016-06-08 | $47.20 | $28K | -17.7% | -21.9% | -12.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.